Cite
HARVARD Citation
Zhang, Z. et al. (2016). Rivastigmine Patch in Chinese Patients with Probable Alzheimer's disease: A 24‐week, Randomized, Double‐Blind Parallel‐Group Study Comparing Rivastigmine Patch (9.5 mg/24 h) with Capsule (6 mg Twice Daily). CNS neuroscience & therapeutics. pp. 488-496. [Online].